Nordic Pharma, Inc., formerly Amring Pharmaceuticals, develops and sells niche generic medicines aimed at prescription markets where few alternatives are available. Launched in the United States and Europe in 2015, the company draws on the technology and capabilities of a nearly 70-year-old healthcare group, including a vertically integrated supply chain spanning development, manufacturing and distribution. It became Nordic Pharma under Nordic Group B.V. ownership in 2024.
BionpharmaFounded in 2014, Bionpharma develops, manufactures, markets, and distributes generic prescription and over-the-counter medicines for U.S. and international markets. The company operates a full-scale pharmaceutical platform with research and development capabilities, a manufacturing site in Chennai, India, and more than 50 marketed drugs. Bionpharma is also one of the largest suppliers of softgel capsules in the United States and has sold its A+ Health OTC line through Amazon since 2019.FLORIDA, NY
Aurobindo Pharma USA, IncAurobindo Pharma USA, Inc. manufactures and distributes generic pharmaceuticals as part of a vertically integrated pharmaceutical operation. Incorporated in the United States in 2004, it lists product manufacturing facilities in New Jersey and emphasizes a broad generic-drug portfolio supplied to wholesalers and retail chains.PEARL RIVER, NY
STI Pharma, LLCFounded in 2008 by industry executive Anup Dam, privately owned STI Pharma develops, licenses, acquires and commercializes generic medicines. The company manages product development and regulatory support in-house, while its commercial products are made at FDA-registered partner facilities and distributed across the United States and its territories. STI is particularly active in specialty and injectable generics, including recent launches such as thiotepa and isoproterenol hydrochloride.NEWTOWN, PA
XGen Pharmaceuticals DJB, IncFounded in 1972 by Dan Badia and his wife, Shirley Harmening, XGen Pharmaceuticals DJB develops and supplies affordable generic pharmaceuticals, with a focus on injectables for hospitals, clinics and institutional customers. The privately held, family-owned and woman-owned company grew from a three-product operation in Northport, New York into a Horseheads-based business whose portfolio preserves essential past-patent treatments, including products such as eribulin mesylate injection. XGen DJB holds NABP accreditation and reports more than 50 years of experience in generic pharmaceuticals.BIG FLATS, NY